Displaying 1 to 1 of 1 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Cambridge Biotechnology Ltd Small molecule drugs for pain and obesity. Aquired by Biovitrum AB in April 2005. |
United Kingdom | 21 Mar 2005 | Acquisition Active |